Aridis In-Licenses Pneumonia Candidate From AstraZeneca

Retrieved on: 2021-07-19 13:52:30

Tags for this article:

Health sciences

Drugs

Health care

AstraZeneca

Medical research

Södertälje Municipality

AZN

Oxford–AstraZeneca COVID-19 vaccine

Aridis Pharmaceuticals Inc.

Click the tags to see associated articles and topics

Aridis In-Licenses Pneumonia Candidate From AstraZeneca. View article details on HISWAI: https://www.benzinga.com/general/biotech/21/07/22039409/aridis-in-licenses-pneumonia-candidate-from-astrazeneca

Excerpt

Aridis Pharmaceuticals Inc (NASDAQ: ARDS) has entered into an exclusive, worldwide licensing agreement with AstraZeneca plc (NASDAQ: AZN) to ...

Article found on: www.benzinga.com

View Original Article